When we break a bone, the damage is obvious. But not every health condition in life is so clear-cut. Many ailments are considered a "silent disease" because they don't have obvious symptoms. Instead, ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Non-alcoholic fatty liver disease (NAFLD) is the physiological manifestation of obesity in the liver. The prevalence of NAFLD has increased from 25.24% in 2015 to 29.38% in 2021, and this condition ...

The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

Get professional help: In addition to advice from your child’s pediatrician, seek out guidance from pediatric obesity ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...

2 There are currently no treatments approved for MASLD, formerly known as nonalcoholic fatty liver disease. Instead, ...

Obesity is a chronic disease with many contributing factors; family history, access to healthy foods, hormonal and metabolic ...

Altimmune’s lead drug Pemvidutide demonstrates significant progress in obesity and liver health. See why ALT stock is a ...

This treatment mediates long-term reversal of liver fibrosis and MASH ... Metabolic dysfunction-associated steatotic liver disease (MASLD), or "fatty liver disease," is the most common chronic liver ...

The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo ...

The risk increases significantly for individuals who carry these viruses long-term without treatment. While Hepatitis B has a ...